{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:16:45Z","timestamp":1789265805142,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04573-5","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:57:59Z","timestamp":1748919479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An open-label phase I comparator-controlled clinical trial to assess tolerability and pharmacokinetics of IHL-675 A a fixed dose combination of cannabidiol plus hydroxychloroquine in healthy volunteers"],"prefix":"10.1038","volume":"15","author":[{"given":"George Williams","family":"Mbogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Kroner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Newchurch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Robert","family":"Bleackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"4573_CR1","doi-asserted-by":"publisher","unstructured":"Wu, D. et al. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. EClinicalMedicine [Internet]. 64, (2023). Available from: https:\/\/doi.org\/10.1016\/j.eclinm.2023.102193","DOI":"10.1016\/j.eclinm.2023.102193"},{"issue":"1","key":"4573_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/can.2018.0073","volume":"5","author":"JM Nichols","year":"2020","unstructured":"Nichols, J. M. & Kaplan, B. L. F. Immune responses regulated by Cannabidiol. Cannabis Cannabinoid Res. 5 (1), 12\u201331 (2020).","journal-title":"Cannabis Cannabinoid Res."},{"key":"4573_CR3","doi-asserted-by":"publisher","unstructured":"Schrezenmeier, E. & D\u00f6rner, T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol [Internet]. 16(3), 155\u201366. (2020). Available from: https:\/\/doi.org\/10.1038\/s41584-020-0372-x","DOI":"10.1038\/s41584-020-0372-x"},{"key":"4573_CR4","doi-asserted-by":"crossref","unstructured":"Fox, R. I. Mechanism of action of hydroxychloroquine as an antirheumatic drug. In: Seminars in Arthritis and Rheumatism. Elsevier 82\u201391 (1993).","DOI":"10.1016\/S0049-0172(10)80012-5"},{"issue":"8","key":"4573_CR5","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","volume":"186","author":"A Ku\u017enik","year":"2011","unstructured":"Ku\u017enik, A. et al. Mechanism of endosomal TLR Inhibition by antimalarial drugs and imidazoquinolines. J. Immunol. 186 (8), 4794\u20134804 (2011).","journal-title":"J. Immunol."},{"issue":"6","key":"4573_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejp.818","volume":"20","author":"DC Hammell","year":"2016","unstructured":"Hammell, D. C. et al. Transdermal Cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur. J. Pain. 20 (6), 936\u2013948 (2016).","journal-title":"Eur. J. Pain"},{"issue":"5","key":"4573_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s13075-014-0437-9","volume":"16","author":"E Krustev","year":"2014","unstructured":"Krustev, E., Reid, A. & McDougall, J. J. Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints. Arthritis Res. Ther. 16 (5), 437 (2014).","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"4573_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0304-3959(01)00454-7","volume":"96","author":"N Clayton","year":"2002","unstructured":"Clayton, N., Marshall, F. H., Bountra, C. & O\u2019Shaughnessy, C. T. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96 (3), 253\u2013260 (2002).","journal-title":"Pain"},{"key":"4573_CR9","doi-asserted-by":"crossref","unstructured":"Kaplan, B. L. F., Springs, A. E. B. & Kaminski, N. E. The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Biochem Pharmacol [Internet]. 2008\/07\/08. 76(6), 726\u2013737. (2008). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18656454","DOI":"10.1016\/j.bcp.2008.06.022"},{"key":"4573_CR10","doi-asserted-by":"crossref","unstructured":"Purohit, R. et al. Patient-Reported Outcomes of Pain, Stiffness, and Fatigue Reduction in Rheumatoid and Psoriatic Arthritis With Cannabinoid Use. Cureus (2024).","DOI":"10.7759\/cureus.72366"},{"key":"4573_CR11","doi-asserted-by":"crossref","unstructured":"Frane, N. et al. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. J. Cannabis Res. 4(1), (2022).","DOI":"10.1186\/s42238-022-00154-9"},{"key":"4573_CR12","doi-asserted-by":"publisher","unstructured":"Devinsky, O. et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. New England Journal of Medicine [Internet]. 2017 May 25 [cited 2021 May 24] 376(21), 2011\u201320. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/nejmoa1611618","DOI":"10.1056\/nejmoa1611618"},{"issue":"20","key":"4573_CR13","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky, O. et al. Effect of Cannabidiol on drop seizures in the Lennox\u2013Gastaut syndrome. N. Engl. J. Med. 378 (20), 1888\u20131897 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"4573_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/jcph.1412","volume":"59","author":"L Taylor","year":"2019","unstructured":"Taylor, L., Crockett, J., Tayo, B. & Morrison, G. A phase 1, Open-Label, Parallel-Group, Single-Dose trial of the pharmacokinetics and safety of Cannabidiol (CBD) in subjects with mild to severe hepatic impairment. J. Clin. Pharmacol. 59 (8), 1110\u20131119 (2019).","journal-title":"J. Clin. Pharmacol."},{"key":"4573_CR15","doi-asserted-by":"publisher","unstructured":"Taylor, L. et al. Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. CNS Drugs [Internet].\u00a032(11), 1053\u201367 (2018). Available from: https:\/\/doi.org\/10.1007\/s40263-018-0578-5","DOI":"10.1007\/s40263-018-0578-5"},{"key":"4573_CR16","unstructured":"Concordia Pharmaceuticals. Plaquenil prescribing information. (2015)."},{"key":"4573_CR17","unstructured":"FDA. Bioanalytical Method Validation: Guidance for Industry (Silver Spring\/Rockville, 2018 May)."},{"issue":"2","key":"4573_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10557-022-07387-z","volume":"38","author":"A Cordova Sanchez","year":"2024","unstructured":"Cordova Sanchez, A., Khokhar, F., Olonoff, D. A. & Carhart, R. L. Hydroxychloroquine and cardiovascular events in patients with rheumatoid arthritis. Cardiovasc. Drugs Ther. 38 (2), 297\u2013304 (2024).","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"4573_CR19","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.18632\/oncotarget.23570","volume":"9","author":"M Shapiro","year":"2018","unstructured":"Shapiro, M. & Levy, Y. The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients. Oncotarget 9 (5), 6615\u20136622 (2018).","journal-title":"Oncotarget"},{"key":"4573_CR20","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/DDDT.S166893","volume":"12","author":"D Liu","year":"2018","unstructured":"Liu, D. et al. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Drug Des. Devel Ther. 12, 1685\u20131695 (2018).","journal-title":"Drug Des. Devel Ther."},{"issue":"11","key":"4573_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","volume":"32","author":"L Taylor","year":"2018","unstructured":"Taylor, L. et al. Placebo-Controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified Cannabidiol in healthy subjects. CNS Drugs. 32 (11), 1053\u20131067 (2018).","journal-title":"CNS Drugs"},{"issue":"8","key":"4573_CR22","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/epi.16093","volume":"60","author":"AK Birnbaum","year":"2019","unstructured":"Birnbaum, A. K. et al. Food effect on pharmacokinetics of Cannabidiol oral capsules in adult patients with refractory epilepsy. Epilepsia 60 (8), 1586\u20131592 (2019).","journal-title":"Epilepsia"},{"issue":"1","key":"4573_CR23","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1038\/s41598-025-87621-4","volume":"15","author":"BADF Saals","year":"2025","unstructured":"Saals, B. A. D. F. et al. A high-fat meal significantly impacts the bioavailability and biphasic absorption of Cannabidiol (CBD) from a CBD-rich extract in men and women. Sci. Rep. 15 (1), 3678 (2025).","journal-title":"Sci. Rep."},{"issue":"4","key":"4573_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/phar.2377","volume":"40","author":"SY Lim","year":"2020","unstructured":"Lim, S. Y., Sharan, S. & Woo, S. Model-Based analysis of Cannabidiol Dose-Exposure relationship and bioavailability. Pharmacotherapy 40 (4), 291\u2013300 (2020).","journal-title":"Pharmacotherapy"},{"issue":"7","key":"4573_CR25","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1007\/s11606-020-06504-8","volume":"36","author":"P Balachandran","year":"2021","unstructured":"Balachandran, P., Elsohly, M. & Hill, K. P. Cannabidiol interactions with medications, illicit substances, and alcohol: a comprehensive review. J. Gen. Intern. Med. 36 (7), 2074\u20132084 (2021).","journal-title":"J. Gen. Intern. Med."},{"key":"4573_CR26","doi-asserted-by":"crossref","unstructured":"Weiss, J., Bajraktari-Sylejmani, G. & Haefeli, W. E. Interaction of hydroxychloroquine with pharmacokinetically important drug transporters. Pharmaceutics 12(10), (2020).","DOI":"10.3390\/pharmaceutics12100919"},{"issue":"1","key":"4573_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kez304","volume":"59","author":"H Wilson-Morkeh","year":"2020","unstructured":"Wilson-Morkeh, H., Al-Abdulla, A., Sien, L., Mohamed, H. & Youngstein, T. Important drug interactions exist between Cannabidiol oil and commonly prescribed drugs in rheumatology practice. Rheumatology 59 (1), 249\u2013251 (2020).","journal-title":"Rheumatology"},{"key":"4573_CR28","doi-asserted-by":"crossref","unstructured":"Godfrey, K. R., Arundel, P. A., Dong, Z. & Bryant, R. Modelling the Double Peak Phenomenon in pharmacokinetics. Comput. Methods Programs Biomed [Internet]. 104(2), 62\u20139. (2011). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0169260710000593","DOI":"10.1016\/j.cmpb.2010.03.007"},{"key":"4573_CR29","doi-asserted-by":"crossref","unstructured":"Dawson, P. A. Bile Secretion and the Enterohepatic Circulation. Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print 1075\u201388 (2010).","DOI":"10.1016\/B978-1-4160-6189-2.00064-0"},{"key":"4573_CR30","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/B978-012088394-3\/50059-3","volume":"2","author":"PA Dawson","year":"2006","unstructured":"Dawson, P. A., Shneider, B. L. & Hofmann, A. F. Bile formation and the enterohepatic circulation. Physiol. Gastrointest. Tract. 2, 1437\u20131462 (2006).","journal-title":"Physiol. Gastrointest. Tract."},{"issue":"8","key":"4573_CR31","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1128\/AAC.00345-10","volume":"54","author":"SP Zvada","year":"2010","unstructured":"Zvada, S. P. et al. Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers. Antimicrob. Agents Chemother. 54 (8), 3390\u20133394 (2010).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04573-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04573-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04573-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:58:02Z","timestamp":1748919482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04573-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4573"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04573-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GWM, PK, RW and MRB are or were employees and shareholders in Incannex Healthcare Pty Ltd. JN has no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"GWM, PK, RW and MRB are or were employees of Incannex Healthcare Pty Ltd and have shares in the company. JN has no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was carried out according to the principles of the Declaration of Helsinki, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline for Good Clinical Practice (GCP) E6(R2) (2016) (as adopted in Australia) and the National Health and Medical Research Council National Statement on Ethical Conduct in Human Research (2007, incorporating all updates). The study protocol was approved by Bellberry Human Research and ethics committee (123 Glen Osmond Road, Eastwood, 5063, South Australia).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Written informed consent was obtained from each subject before any trial-related procedures were performed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"19357"}}